PEAK6
RGLS

PEAK6’s Regulus Therapeutics RGLS Stock Holding History

PEAK6’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,000
Closed -$204K – 3385
2025
Q2 		$204K Buy
+25,000
New +$149K ﹤0.01% 2445

PEAK6's RGLS Position: Q1 2025 in Review

PEAK6 sold out of Regulus Therapeutics (RGLS) in Q1 2025, closing a stake of 60,000 shares — an estimated $94.8K sold.

PEAK6 first reported a position in RGLS in Q4 2024 and held it in 1 quarter. The position peaked at $94.8K in Q4 2024. 75 funds tracked by Wall St. Rank hold RGLS as of Q1 2025.

  • PEAK6 reported no remaining Regulus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • PEAK6 sold 60,000 Regulus Therapeutics shares in Q1 2025, an estimated $94.8K.
  • PEAK6 first reported a position in Regulus Therapeutics in Q4 2024 and held it in 1 quarter.
  • PEAK6's Regulus Therapeutics position peaked at $94.8K in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2025.

Based on PEAK6's 13F filing for Q1 2025, filed 14 May 2025.